Bioelectrical impedance analysis (BIA) and especially its derived parameter phase angle have been widely used in different populations. The variability of BIA measures has often been cited as a major limitation for its clinical use in evaluating nutritional status and overall health of patients. Cancer patients often present with malnourishment and cachexia, which complicate the course of treatment and affect outcomes. PubMed, CINAHL, EBSCO and Cochrane Library have been searched for relevant publications in English for BIA in cancer patients. Out of 197 total results, 27 original research articles related to BIA measures in cancer patients were included in this review. Studies indicate that the use of BIA and phase angle measures can benefit in the clinical management of cancer patients in multiple ways: in the prevention; diagnosis; prognosis; and outcomes related to treatments that affect nutritional and overall health status. Phase angle and fat-free mass measures were most commonly evaluated and correlated with nutritional status and survival rate. One limitation of BIA measures is the high interpatient variability which requires careful interpretation of results in the context of the individual patient rather than comparison with population data. The BIA and phase angle provide practitioners for the evaluation of nutritional and overall health status in cancer patients with a convenient and non-invasive technique and should be encouraged.
INTRODUCTION
Since its introduction in the 1960 s, bioelectrical impedance analysis (BIA) has become a convenient, non-invasive, portable and inexpensive diagnostic tool for the evaluation of body composition. 1 The parameters that can be measured include body fat mass, hydration status (intracellular, extracellular and total water content) and electrolyte composition which are essential in determining the overall health status. 2 Another parameter that is now increasingly used to determine overall health status is the phase angle which is directly based on the reactance and resistance measurements. 1 The phase angle has been used as an indicator for cell membrane integrity, water distribution between the intraand extracellular spaces and prediction of body cell mass-it can thus be used to evaluate the nutritional status of an individual over time. 3, 4 Thus, BIA may be particularly useful to evaluate and predict outcomes related to symptom management of patients with cancer, whose nutritional status and the symptoms are affected by tumors, development of malnutrition and cachexia, tumor-host relations and treatments. 5 The purposes of this paper are to (1) summarize the current scientific and clinical evidence of BIA utility in cancer patients and (2) the implementation of BIA for evaluating outcomes of symptom management and providing supportive care in patients with cancers.
METHODOLOGY
A literature search was conducted through PubMed, CINAHL, EBSCO and Cochrane Library as well as abstracts and graduate thesis publicly available in English literature. Search terms used were 'bioelectrical impedance analysis', 'BIA', 'phase angle', 'malnutrition', 'cachexia' and 'cancer' and combinations of these terms. Inclusion criteria were original research studies which were published in English and utilized BIA and its derived parameter phase angle as observation and predictor variables. All articles were evaluated by at least two authors for inclusion. The search was not restricted to specific dates with the earliest article included dating back to 1994 and the latest was published in 2015. Out of 197 total search results (Table 1) , 37 were not subject related, 103 were duplicates, 12 were written in a foreign language and 18 were review articles ( Figure 1 ). This resulted in 27 original research articles for review (Table 2) .
Bioelectrical impedance analysis and phase angle measures BIA measurements are derived based on linear regression and prediction equations using two values, resistance and reactance, at a specific frequency (often 50 kHz). 1 Resistance is the opposition of an ionic solution in both intra-and extracellular spaces to an applied alternating electrical current, whereas the reactance is based on the dielectric properties of cell membranes and tissue interfaces. These two raw measurements are determined by attaching electrodes to the extremities of a person and applying an electrical current (usually in the μA range). The parameters that are derived from the raw reactance and resistance measures are the fat mass, the fat-free mass, the total body water, the extracellular water content, the intracellular water content and the phase angle ( Figure 2) . 3 The advantage of the phase angle is its relative independence from confounders such as body mass index (BMI) or age since it is a direct derivative of the raw data. Control values of healthy individuals have been determined, although several publications have pointed out that BIA determinations are population and situation specific. 1, 6, 7 However, the BIA measurements over time for an individual with consistent and well-directed guidelines for the measurement procedures may provide useful clinical and diagnostic information about the health status of this individual. 1, 8 The complexity of detrimental effects resulting from both the malignancy and the treatment with chemotherapy adds a significant burden to cancer patients through increased stress and inflammation levels ( Figure 3 ). 9, 10 These, in turn, may lead to gastrointestinal, immune and body composition alterations that can affect energy metabolism and nutrient utilization. 11 The development of cachexia is often seen as a predictor for poor outcomes and results in reduced quality of life (QOL) and delays in treatment schedule. 12 Current use of BIA for determination of health status in cancer patients Over the past years, the application of BIA to assess the health status and predict the outcome of therapy in cancer patients has been studied to some extent. The most commonly used parameter was the phase angle since it incorporates the two directly measured values of resistance and reactance without any further requirement of data derivatization. In a study, the measurement of reactance and resistance was compared among healthy control individuals, cancer patients with local and disseminated malignancies and cancer patients after surgical intervention. 13 Although both groups with malignancies before and after surgical intervention showed a difference in the resistance, it was not significantly different from the healthy controls whereas the reactance and phase angle were significantly lower in both groups compared with the control group. This indicates that the hydration status as measured by the resistance was normal between these groups but the cell membranes and tissue interfaces were significantly affected by both the malignancy and the treatment. The authors proposed that a higher dietary protein content might alleviate the loss in cellular integrity, and therefore would delay or reduce malnutrition and wasting of the body. 13 An important limitation of this study was that patients were free of chemotherapy treatment for at least 4 weeks before the measurements which could influence the outcome.
Another study investigated 399 patients with malignancies and evaluated the phase angle, nutrition status and QOL. 14 In their multiple regression analysis which accounted for the specific tumor type and treatment, the authors observed a strong correlation between the phase angle, the disease severity and the degree of malnutrition in cancer patients.
Association of phase angle with survival rate. In multiple studies including various cancers, a lower phase angle was associated with a significantly lower survival rate, while QOL and global assessment scores from questionnaires proved to be less sensitive and specific.
14-17 Similar conclusions were reached by a recently published review that evaluated several anthropometric measures including BIA, computer tomography and magnetic resonance imaging. 18 These studies did not distinguish among different cancers and therefore may not be applicable to all cancer patients depending on the primary location, potential metastasis development and age of the patient.
The phase angle served as an independent prognostic variable of survival in a study of 259 breast cancer patients. 19 Findings of the study indicated a correlation between phase angle with cancer stage and prior treatment history. Patients who had a phase angle of 5.6°or lower showed a significantly lower median survival time of 23.1 months compared with those who had a higher phase angle which median survival was 49.9 months. A reduction in relative risk by 0.82 for every degree increase in phase angle was noted. One potential issue arising from this study is that the median survival times were compared, which may indicate a non-normal distribution of the data set with skewed results.
The same research group published another study involving the phase angle as a predictor of median survival time in 165 patients diagnosed with stage IIIb or IV non-small cell lung cancer. 20 In this aggressive cancer, the division of the phase angle was determined Figure 1 . PRISMA flow-chart for selection of articles used in the review. 44 Evaluation of malnutrition and quality of life by BIA O Grundmann et al to be 5.3°with median survival at or below this point being 7.6 months and above being significantly longer at 12.4 months independent of cancer stage or prior treatment history. The authors in both studies propose that early nutritional interventions for patients that present with phase angles below the cutoff point may increase the survival time. However, there is no determined nutritional intervention that has been suggested to date to reliably increase the phase angle. A small study in male patients with non-small cell lung cancer indicated a strong negative correlation between tumor volume and phase angle. 21 This also extended to a correlation between tumor volume and overall performance as evaluated by the Karnofsky Performance Scale. It is not surprising that tumor volume impacts physical performance of patients but the correlation with the phase angle may serve as an indicator of progression as well as potential treatment outcome after surgery. A study conducted in the same patient population reported correlations among BIA, subjective assessment, health-related QOL and changes in body weight to the stages of non-small cell lung cancer. 22 A lower phase angle showed a strong correlation with lower QOL, subjective global assessment including malnourishment and overall survival. Although phase angle was not the strongest correlated factor with survival, it provides practitioners with an additional indication for prognosis of the disease.
In a study involving 52 patients with confirmed stage 4 colorectal cancer, phase angle based on BIA and age at diagnosis were the only two parameters that showed statistical significance in survival prediction. 15 The study was conducted over a length of 39 months and patient survival was defined as between the date of the first exam at which phase angle was measured and the date of death or last contact or known to be alive. Phase angle provided for the strongest correlation with survival if the phase angle was above 5.57 (the usual range of phase angle in a healthy population is between 5.64 and 7.90 depending on age and gender). Based on multivariate Cox regression analysis, a phase angle of 5.57°or less increases the relative risk of shortened survival by 10.75. These results indicate that the phase angle can be used as a predicative factor for survival of patients with endstage colorectal cancer.
Derived BIA measures as predictors of cancer development and diagnosis. A study in women with breast cancer evaluated the reliability of bioimpedance spectroscopy (BIS) to determine breast tissue density and fluid changes that could aid in the early diagnosis of breast edema and lymphedema which are precursors to the development of breast cancer. 23 The BIS measurements were repeated in triplicate in 14 women after breast conserving surgery in combination with chemotherapy and/or radiation therapy and measurements were compared with the healthy breast of each woman. The electrodes were applied locally to both breasts. The covariance as an indicator for the reproducibility of the BIS measurements of both the affected and the healthy breasts ranged from 0.20 to 0.86%. One limitation of this study was that the authors did not provide the actual BIS measurements which would be useful for further studies on changes in breast tissue.
The prognostic value of BIA has also been shown in prostate cancer screening in conjunction with a prostate-specific antigen (PSA) test. 24 Although the PSA test alone with a cutoff value of 4 ng/ml showed a sensitivity of 73.9% and a specificity of 51.9%, the difference taken from the BIA measurement (which is the electrical conductivity difference between the left and the right foot) alone showed a sensitivity of 65.2% and a specificity of 85.2% when compared with biopsy results. An algorithm that combined the PSA and BIA delta results (PSA value multiplied by the difference in BIA measurements) with a cutoff value of ⩽ − 10.52 improved both the sensitivity (91.5%) and specificity (59.3%) significantly compared with the PSA test alone. Abbreviations: BCM, body cell mass; BMI, body mass index; BIA, bioelectrical impedance analysis; ECM, extracellular mass; PG-SGA, patient-generated subjective global assessment.
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Another influencing factor in the prognosis of disease progression or regression is the effect of chemotherapy on the individual patient in regard to body composition. A study conducted in 174 patients undergoing chemotherapy 25 evaluated body weight and fat-free mass (FFM) changes in relation to nutrition status at admission. Patients who were already classified as malnourished before chemotherapy lost significant more body weight and FFM than those who were not malnourished following the intervention. FFM is an important indicator of cell integrity and therefore ability of the body to maintain physical functioning following chemical exposure to various tissues as is the case in chemotherapy and radiation. It has been commonly practiced to consider delaying therapy and provide nutritional support first, if patients are malnourished at the beginning of treatment initiation. BIA measurements may aid in the diagnostic process of nutritional status in patients before treatment intervention.
There have been indications that several BIA-derived measures such as FFM, fat mass, body weight and BMI are correlated with the risk of developing colon cancer and potentially other cancers. 26, 27 A study evaluated a total of 16 556 men from four different countries (Australia, United Kingdom, Italy and Greece) over the course of 8-12 years following the initial evaluation.
2 BIA measurements were obtained at the initial evaluation in addition to the health questionnaires and other measurements. At the end of the observation period, a total of 153 colon cancers had been diagnosed. Of the diagnosed cases, multiple regression models were constructed to derive rate ratios (comparison between fourth and first quartile in the population) after adjustment for age, country of birth and level of education. There were significant correlations between the risks of developing colon cancer with increased weight, increased FFM, increased fat mass and increased BMI. The authors concluded that the BIA measures of FFM and fat mass can serve as predictors of risk for the development of colon cancer in association with weight and BMI determination with the limitation that BIA measures are assumed to be taken from individuals that are well hydrated which is complicated to account for in a study.
Evaluation of nutritional status using BIA measures Prognostic value of the phase angle to detect cachexia in cancer patients. A study of pre-and post-hydration status and the phase angle including a small sample size of 50 advanced cancer patients indicates that initially a higher phase angle was associated with longer survival time whereas an increase in the phase angle during hydration led to a drop in median survival time. 28 As was expected based on the literature, weight loss during the observation period was also associated with a lower median survival time. The increase in phase angle following hydration did not benefit patients in this study potentially because of the loss of cell integrity. Since no other BIA measures were collected or reported it is not clear how this relates to total body water or FFM.
The supplementation with creatine to colorectal cancer patients has been studied to evaluate QOL and phase angle using subjective questionnaires and BIA. 29 Thirty-one patients with colorectal cancer were randomly assigned to either creatine or placebo group in addition to their respective therapy regimen and Increases in inflammation and stress levels are a result of the invasive and aggressive tumor which activates the immune system as well as the increased stress level because of treatment. This in turn leads to activation of the autonomic nervous system with a shift toward the sympathetic branch away from homeostasis. Indirectly, these effects then cause changes in gastrointestinal motility, decreased immune function and changes in body composition (primarily loss of lean muscle mass followed by reduction in fat tissue leading to malnutrition and cachexia).
were evaluated before starting the trial and after 8 weeks. Although creatine intervention did not improve QOL, muscle mass or physical function, the phase angle and body cell mass increased significantly compared with the placebo group. The authors conclude that the phase angle is an established predictor for outcome and therefore hypothesize that the patients in the creatine treated group may have a longer survival period compared with placebo group. However, the survival time could not be predicted since there was no follow-up beyond the 8 week of supplementation period for the study.
Both gastric cancer and colorectal cancer often require aggressive treatment, and lead to significant weight loss and cachexia in patients. A study compared various objective and subjective assessment tools in regards to how well they correlated with the patient-generated subjective global assessment (PG-SGA), the current gold standard of patient nutritional status evaluation. 30 The cross-sectional study included 137 patients divided into two groups; one group currently being treated for gastric or colorectal cancer and a follow-up group after completion of treatment. Objective measurements included were the BMI, phase angle and serum albumin as well as the nutritional screening tools (malnutrition universal screening tool, malnutrition screening tool and nutritional risk index). Regression analysis revealed that the nutritional screening tools showed better association with the PG-SGA overall than the objective measurement tools. Among the objective measurement tools, the phase angle showed the best association in terms of sensitivity with the PG-SGA. The authors suggest combining the PG-SGA as a subjective measurement tool with the malnutrition universal screening tool to achieve the best sensitivity and specificity to detect cachexia and follow it over the course of the treatment and aftercare.
Although weight loss or BMI are often considered as measures for determination of malnourishment in patients, a study of 51 patients with hepatocellular carcinoma reported that neither BMI nor weight loss were reliable predictors for malnourishment. 31 The study correlated subjective assessment scores as well as phase angle and other BIA measures to the development of malnourishment and determined a cutoff value of 4.8°for the phase angle to be a reliable independent predictor for malnourishment in this patient population. However, the limitations were a small sample size and a lack of correlation with cancer stand age.
The correlation between subjective assessment tools such as the PG-SGA or the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (QLQ-C30) and objective measures such as the phase angle can provide a more distinct insight into the overall health of a patient. A study in 58 colorectal cancer patients indicates that several QLQ-C30 dimensions correlate with phase angle, especially global health, fatigue, role and physical health. 32 In the same study, the researchers concluded that malnourishment was associated with poor outcomes and quality of health in patients which is well supported by the literature in general.
In a similar study in 73 patients with stages 3 and 4 colorectal cancer, the same research group categorized patients based on the subjective global assessment scale as either well-nourished or malnourished. 33 Patients were also evaluated using BIA and the phase angle was determined at 50 kHz. The nutrition status was correlated with the phase angle via a Spearman correlation coefficient since the data were not normally distributed. The correlation was significantly different for patients who were classified as well nourished compared with those who were categorized as moderately or severely malnourished with a higher phase angle in those who were well-nourished (median phase angle was 6.12 compared with 5.18 for the malnourished patients). The authors then defined various cutoff values for the phase angle that would constitute malnourishment. At a phase angle cutoff value of 5.2, the sensitivity was 51.7% and the specificity to detect malnutrition was 79.5%. Once the cutoff value for the phase angle is raised to 5.7, the sensitivity increases to 69.0%, while the specificity decreases to 56.8%.
Derived BIA measures as an evaluation tool for the risk of developing cachexia. Several indicators have been used to evaluate if somebody is at risk of developing cachexia. Among them, the midarm muscle area and circumference have been frequently used and are associated with malnutrition. In a study with 70 colorectal cancer patients, various parameters were evaluated and their association with the subjective global assessment score as well as the Glasgow prognostic score as an indicator for inflammation and nutritional status determined. 34 Patients were categorized into one group with no signs of malnourishment and another with severe malnourishment based on the patientgenerated subjective global assessment (PG-SGA). The malnourished group presented with a high prevalence of complications during their therapy. Although the various parameters were significantly different between the two groups, only the midarm circumference as well as the BMI could be distinguished between the group with mild or suspected malnourishment and the group with severe malnourishment. Although the phase angle was also evaluated, it was not an as sensitive tool to detect malnourishment in suspected or moderately affected patients as other tools used in this study.
A phase II study 4 reported that the BIA provided predictive value in the parenteral nutrition supplementation in 65 patients with advanced pancreatic cancer. Overall, over the course of the study, several parameters improved among patients, especially the BMI as an indicator of increased nutrition, the phase angle as a predictive value for survival and the ratio of extracellular mass (ECM) and body cell mass (BCM). The BMI increased from 19.7 to 20.5, while the phase angle improved by 10% from 3.6 to 3.9. The ECM/BCM ratio is a sensitive indicator of malnutrition since it provides the ratio of connective, bone and non-metabolizing tissue and all the actively metabolizing tissues. The ECM/BCM ratio in healthy individuals is always o 1 since the metabolizing tissue is present in higher amounts than the non-metabolizing tissue. A rising ECM/BCM ratio therefore is an early warning sign for worsening nutritional and metabolic status. The ECM/BCM ratio decreased in this study from 1.7 to 1.5 over the course of 2 years. The ECM/BCM ratio was also evaluated in a study including 75 patients with head and neck cancer and they were divided into well-nourished and malnourished groups based on the subjective global assessment procedure. 35 Similar to the pancreatic cancer study, patients with a lower ECM/BCM ratio were significantly better nourished with a cutoff value for classification as malnourished determined to be 1.194 or higher. This cutoff value for head and neck cancer was determined to be 76% sensitive and 63% specific in detecting malnourishment in this patient population. These studies provide valuable insights into the uses of BIA and derived values for the evaluation of cancer patients; however, findings were also limited because of the small sample sizes and the specific populations that were not compared with healthy individuals.
A similar study was conducted in a diverse population of patients with advanced cancer in order to determine the value of parenteral nutrition in addition to enteral nutrition support. 36 Over the course of 48 weeks, 152 patients were being followed and their BMI, caloric intake, BIA, albumin and hemoglobin in 6-week intervals. The patients were randomized into either receiving enteral nutrition support alone or enteral nutrition support with parenteral nutrition. QOL was assessed using the QLQ-C30 questionnaire. After 6 weeks, there was a significant improvement in the parenteral nutrition group in BCM, mean QOL and mean albumin, while the BMI did only indicate significant differences and improvement for the parenteral nutrition group after 48 weeks. The survival rate was also significantly higher in patients with parenteral nutrition support. According to the authors, parenteral nutrition is not regarded as a standard of care treatment for patients with advanced cancers. These studies indicate that BIA measures may serve as early indicators for improvement in nutritional and health status in the diverse cancer population where the BMI may not be an as sensitive and early indicator to predict survival and QOL.
Another small pilot study investigated the use of acupuncture to increase appetite and decrease adverse effects of chemotherapy treatment in seven patients with gastrointestinal cancers. 37, 38 During the 8-week intervention, patients reported an increase in QOL and BIA measures indicated that the shift in intracellular to extracellular fluid was not significant compared with the baseline. This indicates that cell integrity may remain stable. Despite these preliminary positive outcomes, patients still lost weight and the phase angle decreased over time although not as drastically as is reported in the literature.
The importance of establishing correlations between various objective and subjective parameters in predicting the nutritional status of cancer patients has resulted in an extensive search to establish a good protocol. One small study evaluated the relationship between nutritional status as evaluated by the resting energy expenditure (REE) using two methods (either indirect calorimetry or Harris Benedict formula) with BIA and specifically BCM as an indicator for metabolic activity in gastric cancer patients (n = 13) compared with a healthy control group (n = 18). 39 In this study, the REE as evaluated by indirect calorimetry served as the gold standard and the ratio of the REE and the BCM as well as the REE and weight were compared with each other. For both ratios, the gastric cancer group showed a significantly higher energy expenditure indicating increased metabolic activity which may result in loss of weight and fat-free body mass. This increased metabolic activity then can result in cancer cachexia with overall decreased function and potential for inflammation. The authors conclude that the best parameter for determination of nutritional status and development of cachexia remains the REE via indirect calorimetry since no linear relationship could be established between the BCM, body weight or REE using the Harris Benedict formula. Conclusions of the study are fairly limited because of the small sample size and the limited parameters used to establish a comparison. A larger study compared the REE and various BIA measures in 714 cancer patients with the same measures in 642 healthy controls. 40 As has been shown before, cancer patients presented with a higher REE which correlated with lower BCM, extracellular fluid and fat oxidation. Given the nature of increased energy metabolism, it is common to see a shift in oxidative metabolism from carbohydrates to fats resulting in elevated FFM indicative of malnutrition which can advance to cachexia. The authors of this large study are careful with generalizing their results and highlight that the degree of deviation from normal body composition depends on the type and stage of cancer. 40 Nutritional and supportive intervention should be considered for all patients undergoing chemotherapy or radiation. The additional use of the phase angle in addition to the BMI may have provided further information and potential establishment of a correlation with nutritional status in these studies.
Application of phase angle to specific populations One of the main issues in correlating the phase angle to many other parameters is the non-parametrical distribution of values that complicates the definition of cutoff values in a given population. Of importance is that the phase angle can only be applied to a defined population and allow for comparison among the population and not outside of it. The normal range for the phase angle is wide ranging from 3 to 10, thus limits comparisons among different groups. Especially in cancer populations, the variability of the phase angle is wide and may require consideration of additional parameters such as age, sex and health status.
14 Furthermore, it has been shown that BIS and BIA frequently underestimate body composition variables in cancer patients compared with dual-energy X-ray absorptiometry. 41 Some of these deviations can be compensated for by using adequate mathematical transformations accounting for BMI or weight of the patient but phase angle and FFM may deviate significantly between individuals. However, another small exploratory study in 24 patients with head and neck cancer compared the FFM measured via BIA and dual-energy X-ray absorptiometry over the course of radiation treatment and did not find a significant difference between the measurement methods. 42 Given the easy measurement using BIA instead of the more involved X-ray absorptiometry the authors conclude that the determination of FFM can be easily made using BIA although the study has the limitation of a small sample size and is limited to only FFM as a BIA measure. FFM may also be correlated to objective measures obtained from inflammatory markers such as tumor necrosis factor-alpha and serum albumin levels as determined by a small study in hepatocellular carcinoma patients compared with cirrhotic patients. 43 The correlation between inflammatory markers and FFM was significant with worsening stages of the malignancy serving as potential prognostic indicators for the disease progression. This small study may lead to the use of correlations between objective measures instead of subjective questionnaires in determining overall health and potential treatment approaches. Based on the current comparative research results, it remains essential to follow the patient throughout therapy and record phase angle changes for each individual to allow for a greater predictive value to apply to the specific patient over time. This may be one of the most restrictive limitations of the utilization of the phase angle in clinical practice.
CONCLUSIONS
BIA has been studied for many years and used both in the prevention and diagnosis of overall health status in a variety of conditions. Especially in cancer patients, nutrition and hydration status are important predictors and parameters for overall wellbeing and are being used in the decision process on the best treatment schedule for patients. BIA has been used to assess health status providing for better evaluation of the patient as well as a predictive tool in outcomes for cancer patients. The phase angle, which is a direct derivative of the reactance and resistance measurements, has shown a good correlation with outcome and health status in several diverse cancer populations and even in comparison with healthy control populations. Although some recent and earlier studies are likely too small and underpowered to generalize the findings, the overall conclusion is that a reduction in phase angle serves as a predictor for poor health status as well as poor outcome and lower survival in cancer patients. The prognostic value for survival and treatment outcomes has been well established for the phase angle which is also correlated with the specific cancer and stage of the malignancy.
The limitations of BIA measures are that they cannot be extrapolated to other populations; individual patients have to be followed throughout treatment to establish changes in phase angle that can be predictive in nature, and that measurements have to be taken in well hydrated individuals in order to be comparable. The best use of BIA measurements is the evaluation of individuals over time to provide for a longitudinal change of phase angle as the individual develops disorders, receives treatment and progresses through the intervention. Further research on the diagnostic value and clinical applications of the BIA and the phase angle should be conducted to strengthen and increase its use in clinical practice.
